Summit Therapeutics PLC (SMMT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $11.32B
Last updated: Nov 17, 2026 at 4:43 PM ET
Summit Therapeutics PLC (SMMT) Stock Chart
Summit Therapeutics (SMMT) has a latest price of $10.67 on Nov 17, 2026. Its price fell 40.8% over the past 12 months. The month-end price rose 36.2% over the 10 years through Oct 2026, a compound annual rate of 3.1%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $26.37 in Jul 2025 and its lowest $0.80 in Nov 2022, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart SMMT with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for SMMT.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 18.6%, and over 6 months it fell 32.7%. The month-end price rose 726.3% over the 3 years through Oct 2026, a compound annual rate of 102.2%.
| Period | Change |
|---|---|
| 1 month | -31.5% |
| 3 months | -18.6% |
| 6 months | -32.7% |
| 12 months | -40.8% |
| 12 months, with dividends | -40.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +726.3% | +102.2% |
| 5 years | +210.7% | +25.4% |
| 10 years | +36.2% | +3.1% |
Price by Year
Its best calendar year was 2024, when the price rose 583.7%, and its weakest was 2018, when it fell 89.6%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $16.03 | -8.3% |
| 2025 | $17.49 | -2.0% |
| 2024 | $17.84 | +583.7% |
| 2023 | $2.61 | -38.6% |
| 2022 | $4.25 | +58.0% |
| 2021 | $2.69 | -42.8% |
| 2020 | $4.70 | +193.8% |
| 2019 | $1.60 | +39.1% |
| 2018 | $1.15 | -89.6% |
| 2017 | $11.08 | +29.4% |
Trading Range
The price is 34.0% below its 50-day average of $16.16 and 33.8% below its 200-day average of $16.12.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $10.67 | |
| 50-day average | $16.16 | -34.0% |
| 200-day average | $16.12 | -33.8% |
Price Risk
Over 3 years, its largest fall from a peak was 70.9%.
| Measure | Value |
|---|---|
| 1-year beta | 2.06 |
| Largest fall, 1 year | -59.6% |
| Largest fall, 3 years | -70.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About SMMT
What is SMMT's 1-year price change?
Summit Therapeutics's price fell 40.8% over the past 12 months. With dividends included, the 12-month total return was -40.8%.
What is SMMT's 5-year price change?
Summit Therapeutics's month-end price rose 210.7% over the 5 years through Oct 2026, a compound annual rate of 25.4%. These figures leave out dividends.
What is SMMT's beta?
Summit Therapeutics's 1-year beta against the S&P 500 is 2.06, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 59.6%.
Is the SMMT chart free?
Yes. Advanced Charting for SMMT is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
SMMT pages: Overview, Charting, Competitors